TY - JOUR
T1 - The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity
T2 - A potential mechanism for thrombosis in eosinophilic inflammatory states
AU - Wang, Jian Guo
AU - Mahmud, Shawn A.
AU - Thompson, Jacob A.
AU - Geng, Jian Guo
AU - Key, Nigel S.
AU - Slungaard, Arne
PY - 2006/1/15
Y1 - 2006/1/15
N2 - In vivo, bromide (Br-), nitrite (NO2-), and thiocyanate (SCN-) compete for oxidation by eosinophil peroxidase (EPO) and H2O2, yielding, respectively, HOBr, NO 2·, and HOSCN. We have recently shown that SCN- is the strongly preferred substrate for EPO in vivo and that HOSCN, in contrast with other EPO-generated oxidants and HOCl, is a relatively weak, cell-permeant, sulfhydryl (SH)-reactive oxidant. We here show that HOSCN is a uniquely potent (up to 100-fold) phagocyte oxidant inducer of tissue factor (TF) activity in human umbilical vein endothelial cells (HUVECs). This induction is attributable to transcriptional up-regulation of TF gene expression dependent upon both activation of the p65/c-Rel TF-κB transcription factor and activity of the ERK1/2 kinase pathway upstream of Egr-1 and was markedly further enhanced in the presence of wortmannin, an inhibitor of the PI3 kinase/Akt pathway. HOSCN also markedly activates the proinflammatory p65/p50 NF-κB pathway. Based on these findings we hypothesize that HOSCN generated by adherent and infiltrating eosinophils may provoke the development of a prothrombotic and proinflammatory endothelial/endocardial phenotype that promotes the pronounced thrombotic diathesis characteristic of the hypereosinophilic syndrome.
AB - In vivo, bromide (Br-), nitrite (NO2-), and thiocyanate (SCN-) compete for oxidation by eosinophil peroxidase (EPO) and H2O2, yielding, respectively, HOBr, NO 2·, and HOSCN. We have recently shown that SCN- is the strongly preferred substrate for EPO in vivo and that HOSCN, in contrast with other EPO-generated oxidants and HOCl, is a relatively weak, cell-permeant, sulfhydryl (SH)-reactive oxidant. We here show that HOSCN is a uniquely potent (up to 100-fold) phagocyte oxidant inducer of tissue factor (TF) activity in human umbilical vein endothelial cells (HUVECs). This induction is attributable to transcriptional up-regulation of TF gene expression dependent upon both activation of the p65/c-Rel TF-κB transcription factor and activity of the ERK1/2 kinase pathway upstream of Egr-1 and was markedly further enhanced in the presence of wortmannin, an inhibitor of the PI3 kinase/Akt pathway. HOSCN also markedly activates the proinflammatory p65/p50 NF-κB pathway. Based on these findings we hypothesize that HOSCN generated by adherent and infiltrating eosinophils may provoke the development of a prothrombotic and proinflammatory endothelial/endocardial phenotype that promotes the pronounced thrombotic diathesis characteristic of the hypereosinophilic syndrome.
UR - http://www.scopus.com/inward/record.url?scp=30444436766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=30444436766&partnerID=8YFLogxK
U2 - 10.1182/blood-2005-05-2152
DO - 10.1182/blood-2005-05-2152
M3 - Article
C2 - 16166591
AN - SCOPUS:30444436766
SN - 0006-4971
VL - 107
SP - 558
EP - 565
JO - Blood
JF - Blood
IS - 2
ER -